Inmedix, Inc. — Form D
Inmedix, Inc. of NORMANDY PARK, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-01. The offering totals $3.5M, of which $720K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-01
- Form: D
- Accession: 0001851853-24-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $3.5M
- Amount sold: $720K
- Remaining: $2.8M
- Minimum investment: $20K
- Investors: 5
- Date of first sale: 2024-08-23
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-528464
Issuer
- Name: Inmedix, Inc.
- CIK: 0001851853
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 17837 FIRST AVENUE SOUTH, #6, NORMANDY PARK, WA, 98148
- Phone: 2064125347
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Bernie Tobin | Director | Normandy Park, WA |
| Andrew Holman, M.D. | Director | Normandy Park, WA |
| Andrew Holman, M.D. | Executive Officer | Normandy Park, WA |
| Steven Daly, M.S., M.B.A. | Director | Normandy Park, WA |
| Leroy Hood, M.D., Ph.D. | Director | Normandy Park, WA |
| Kevin Tracey, M.D. | Director | Normandy Park, WA |
| Ryan Sullivan, Ph.D. | Director | Normandy Park, WA |
| Steven J Daly | Director | Seattle, WA |
| Andrew J Holman | Director | Seattle, WA |
| Andrew J Holman | Executive Officer | Seattle, WA |
| Bernie J Tobin | Director | Seattle, WA |
Other filings by this issuer (4)
More